Quantum Biopharma Ltd (QNTM) Stock Price, Quote & News

Company Profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a patented new chemical enti...

Industry: Biotechnology

Sector: Healthcare

Phone: 833 571 1811

Website: www.quantumbiopharma.com

Address:

1 Adelaide Street East, Suite 801, Toronto, Canada

GPDL May. 13 at 6:20 PM

$QNTM Nice cup and handle

0 · Reply

MorganHoratio May. 13 at 5:13 PM

Top quantum names to watch:(PART3) ETF exposure: • $QTUM.X • $QNTM • $CHPX Don’t want to gamble on a single tech path? These ETFs are your "Strategic Shield"! 🚀 $QTUM.X just surpassed $4B in AUM, and its 35% YTD return proves the smart money is pouring in. $CHPX is also a powerhouse, capturing the synergy between semiconductors and quantum in the 2nm era. As a fellow holder, I believe ETFs are the safest bet for the 2026 quantum boom. Are you backing the diversified approach of $QTUM.X or leaning towards more hardware-centric plays? Let’s discuss in the comments! 👇

1 · Reply

Vapor83 May. 12 at 3:05 PM

$QNTM trial news any day now (positive news) and the second IR firm starts Monday.

0 · Reply

Rambler1111 May. 11 at 7:21 PM

$QNTM It’s been very QUIET for a company who announced they hired a PR company a few weeks ago. I really hope they unleash some big news soon and justify the reason they were hired .

0 · Reply

IronSpartan May. 11 at 6:37 PM

$QNTM Quantum + pharma? interesting

0 · Reply

Rambler1111 May. 11 at 6:36 PM

$QNTM

0 · Reply

Vapor83 May. 9 at 1:59 PM

$QNTM guessing we get trial news this week and a 100% jump

0 · Reply

FickleFin May. 8 at 2:40 PM

$QNTM $GNS its called... leverage. Paid by retail investors. They pump. They pocket. This company is a lie. 2nd picture is 3 different aliases under 1 person stating the same narrative but cross tagging different tickers. 🚩🚩🚩🚩

1 · Reply

ZacksResearch May. 7 at 7:02 PM

$QNTM just doubled its liquidity — and the biotech pipeline is still moving full speed 🚀 💰 Cash, cash equivalents + digital assets jumped to $9.8M in Q1, up from $4.1M at year-end 📉 Operating cash burn dropped 60% YoY after Phase 1 trial completion 🧬 Lucid-MS IND officially submitted to the FDA, with Phase 2 plans advancing alongside Allucent Meanwhile, management says current liquidity could fund operations through approximately July 2027. See what Wall Street expects next 👉 https://www.zacks.com/stock/research/QNTM/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38021&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38021

1 · Reply

Ronin275 May. 7 at 12:04 PM

$QNTM https://feeds.issuerdirect.com/news-release.html?newsid=8057852677373016&symbol=QNTM

1 · Reply

Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026

Mon, 27 Apr 2026 19:45:00 -0400 - 16 days ago

Quantum BioPharma Provides Corporate Update

Wed, 22 Apr 2026 09:16:00 -0400 - 21 days ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant

2026-04-01T12:25:14.000Z - 6 weeks ago

Quantum BioPharma submits Lucid-21-302 new drug application to the FDA

Wed, 01 Apr 2026 08:02:00 -0400 - 6 weeks ago

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

2026-03-30T12:47:57.000Z - 6 weeks ago

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

2026-03-30T12:28:19.000Z - 6 weeks ago

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

Mon, 30 Mar 2026 07:50:00 -0400 - 6 weeks ago

Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis

Fri, 27 Mar 2026 19:30:00 -0400 - 6 weeks ago

Quantum Biopharma Provides Corporate Update

Fri, 27 Mar 2026 08:10:00 -0400 - 6 weeks ago

Quantum Biopharma's 2025 Audited Year End Financial Results Maintain ‘No Going Concern' Status

Mon, 23 Mar 2026 08:24:00 -0400 - 7 weeks ago

Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

Fri, 20 Mar 2026 19:35:00 -0400 - 7 weeks ago

Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering

Wed, 11 Mar 2026 19:55:00 -0400 - 2 months ago

Quantum BioPharma Provides Corporate Update

Thu, 19 Feb 2026 19:29:00 -0500 - 2 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

Thu, 19 Feb 2026 12:00:00 -0500 - 2 months ago

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Tue, 17 Feb 2026 13:55:00 -0500 - 3 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma, Ltd. Investors

Tue, 17 Feb 2026 12:59:00 -0500 - 3 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Tue, 17 Feb 2026 09:41:00 -0500 - 3 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Corporation Investors

Thu, 12 Feb 2026 16:02:00 -0500 - 3 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

Tue, 03 Feb 2026 13:12:00 -0500 - 3 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Mon, 02 Feb 2026 10:46:00 -0500 - 3 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors

Tue, 27 Jan 2026 13:42:00 -0500 - 3 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Dec 23, 2025, 8:00 AM EST - 5 months ago

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

Mon, 22 Dec 2025 09:00:00 -0500 - 5 months ago

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

Dec 10, 2025, 8:00 PM EST - 5 months ago

Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update

2025-12-01T12:15:18.000Z - 5 months ago

Quantum BioPharma announces airing of news segment on manipulation lawsuit

Nov 27, 2025, 4:00 PM EST - 5 months ago

Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC

Nov 26, 2025, 9:30 AM EST - 6 months ago

Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

2025-11-07T12:12:42.000Z - 6 months ago

Quantum BioPharma reports Q3 EPS ($1.25) vs. (4.37) last year

2025-11-07T12:11:35.000Z - 6 months ago

Quantum BioPharma sees cash runway beyond March 2027

Nov 7, 2025, 7:00 AM EST - 6 months ago

Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

Oct 31, 2025, 7:51 PM EDT - 6 months ago

Quantum BioPharma Ltd. Provides Corporate Update

Oct 29, 2025, 9:00 PM EDT - 6 months ago

Quantum BioPharma Ltd. Announces Corporate Updates

Oct 23, 2025, 8:15 AM EDT - 7 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication

2025-10-20T12:40:40.000Z - 7 months ago

Quantum BioPharma announces expiration of warrants held by hedge funds

Oct 20, 2025, 8:30 AM EDT - 7 months ago

Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

Oct 14, 2025, 8:15 AM EDT - 7 months ago

Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group

Oct 9, 2025, 6:00 PM EDT - 7 months ago

Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM

Oct 9, 2025, 5:40 PM EDT - 7 months ago

QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm

2025-10-08T12:15:28.000Z - 7 months ago

Quantum BioPharma offers cash reward up to $7M for market manipulation proof

Oct 8, 2025, 8:00 AM EDT - 7 months ago

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Oct 7, 2025, 11:00 AM EDT - 7 months ago

Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

2025-10-03T11:10:25.000Z - 7 months ago

Quantum BioPharma announces record date for special dividend distribution

Oct 3, 2025, 7:00 AM EDT - 7 months ago

Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

2025-10-02T12:00:38.000Z - 7 months ago

Quantum BioPharma receives final reports for two studies of Lucid-21-302

Oct 2, 2025, 7:57 AM EDT - 7 months ago

Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

2025-10-01T11:55:37.000Z - 8 months ago

Quantum BioPharma appoints Jack Antel as clinical development advisor

Oct 1, 2025, 7:50 AM EDT - 8 months ago

Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

2025-09-29T11:45:06.000Z - 8 months ago

Quantum BioPharma announces Annual General, Special Meeting results

Sep 29, 2025, 7:40 AM EDT - 8 months ago

Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders

Sep 26, 2025, 8:00 PM EDT - 8 months ago

Quantum BioPharma Announces Corporate Updates

Sep 24, 2025, 8:30 AM EDT - 8 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025

Sep 18, 2025, 8:10 AM EDT - 8 months ago

Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance

Sep 12, 2025, 7:50 AM EDT - 8 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT

Sep 10, 2025, 7:00 AM EDT - 8 months ago

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

Aug 11, 2025, 6:32 PM EDT - 9 months ago

Quantum BioPharma Announces Update to Previously Announced Private Placement

Aug 11, 2025, 7:40 AM EDT - 9 months ago

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

2025-08-08T12:10:18.000Z - 9 months ago

Quantum BioPharma announces results from study on PET tracer

Aug 8, 2025, 8:00 AM EDT - 9 months ago

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

Aug 7, 2025, 7:00 AM EDT - 9 months ago

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt

Aug 5, 2025, 7:34 AM EDT - 10 months ago

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Aug 4, 2025, 7:33 AM EDT - 10 months ago

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

Jul 31, 2025, 7:24 AM EDT - 10 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Jul 22, 2025, 7:00 AM EDT - 10 months ago

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

GME

Jun 27, 2025, 4:30 PM EDT - 11 months ago

Quantum BioPharma Announces Private Placement

Jun 26, 2025, 7:30 AM EDT - 11 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Jun 18, 2025, 9:19 AM EDT - 11 months ago

Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress

Jun 17, 2025, 8:00 AM EDT - 11 months ago

Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital

Jun 13, 2025, 7:00 AM EDT - 11 months ago

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

Jun 3, 2025, 7:50 AM EDT - 1 year ago

Quantum BioPharma Clarifies It Has Not Changed Its Name

Jun 2, 2025, 1:47 PM EDT - 1 year ago

iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients

May 30, 2025, 7:00 AM EDT - 1 year ago

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

May 29, 2025, 7:30 AM EDT - 1 year ago

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

May 28, 2025, 8:00 AM EDT - 1 year ago

Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome

GPDL May. 13 at 6:20 PM

$QNTM Nice cup and handle

0 · Reply

MorganHoratio May. 13 at 5:13 PM

1 · Reply

Vapor83 May. 12 at 3:05 PM

$QNTM trial news any day now (positive news) and the second IR firm starts Monday.

0 · Reply

Rambler1111 May. 11 at 7:21 PM

$QNTM It’s been very QUIET for a company who announced they hired a PR company a few weeks ago. I really hope they unleash some big news soon and justify the reason they were hired .

0 · Reply

IronSpartan May. 11 at 6:37 PM

$QNTM Quantum + pharma? interesting

0 · Reply

Rambler1111 May. 11 at 6:36 PM

$QNTM

0 · Reply

Vapor83 May. 9 at 1:59 PM

$QNTM guessing we get trial news this week and a 100% jump

0 · Reply

FickleFin May. 8 at 2:40 PM

1 · Reply

ZacksResearch May. 7 at 7:02 PM

1 · Reply

Ronin275 May. 7 at 12:04 PM

$QNTM https://feeds.issuerdirect.com/news-release.html?newsid=8057852677373016&symbol=QNTM

1 · Reply

FickleFin May. 7 at 10:27 AM

$QNTM $GNS Dilution is the solution. 😄😄😄🥴 red flag after red flag... then you get the pumps. Notice the pattern??

0 · Reply

Vapor83 May. 7 at 1:22 AM

$QNTM good pop coming soon

0 · Reply

Wearewhowethought May. 6 at 9:39 PM

$GNS $MMTLP $QNTM rest a assure if there is any type of mmtlp payout that team of 60k shareholders is going buy yhe gns float and jamm it ip vitus a hole

0 · Reply

Wearewhowethought May. 6 at 9:18 PM

$GNS $MMTLP $QNTM https://www.businesswire.com/news/home/20251117989078/en/Grant-Eisenhofer-Files-Class-Action-Lawsuit-Against-Citadel-Securities-LLC-and-Virtu-Americas-LLC

0 · Reply

Vapor83 May. 6 at 9:09 PM

$QNTM https://www.prnewswire.com/news-releases/fernando-mendoza-and-family-launch-mendoza-family-fund-with-national-ms-society-ahead-of-draft-day-302751790.html

0 · Reply

OfficialStocktwitsUser May. 6 at 4:07 PM

$QNTM RSI: 78.33, MACD: 0.5065 Vol: 1.07, MA20: 4.10, MA50: 3.71 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

FickleFin May. 5 at 10:32 AM

$QNTM $GNS thieves from Shitco companies trying Citadel. Good Luck.

0 · Reply

Vapor83 May. 5 at 1:55 AM

$QNTM

1 · Reply

Ginelle2424 May. 4 at 8:45 PM

$QNTM

0 · Reply

tenbaggerz May. 4 at 4:36 PM

$ELPW guys be careful this can reverse very quickly traders familiar with the stock know what I am talking about protect your gains and move on I am long $QNTM multibagger just getting started

0 · Reply

ChadMinton May. 4 at 12:56 PM

$QNTM $7

0 · Reply

FickleFin May. 4 at 12:23 PM

$QNTM $GNS all pump now for this sh!t stock. Toxic doggie has multiple aliases. So does fucking Malone. (TWIT) Who the fuck pats himself on the back for running his mouth. You guys keep getting played... they are literally paying for bots, third party shitcos to promote company. 🥴

0 · Reply

Market Cap	19.31M
Revenue (ttm)	0.00
Net Income (ttm)	-26.18M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	150,500
Avg Vol	512,976
Day's Range	N/A - N/A
Shares Out	3.82M
Stochastic %K	39%
Beta	0.29
Analysts	Sell
Price Target	$35.50